BioAdvance News NuPathe Portfolio News

NuPathe Wins U.S. FDA Approval for Migraine Skin Patch

By WebmasterJanuary 18, 2013November 1st, 2024No Comments

NuPathe Wins U.S. FDA Approval for Migraine Skin Patch
Read more here

Previous PostCeptaris Announces Publication in JAMA Dermatology of Positive Clinical Results
Next PostInfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector